Altered galectin-3 distribution and migratory function in the pre-diabetic non-obese diabetic mouse thymus
Galectin-3 is an endogenous lectin which binds mainly to β-galactosides on the cell surface and extracellular matrix (ECM) glycoproteins. In the thymus, this lectin is constitutively expressed, being involved in thymocyte adhesion, migration, and death. Galectin-3 has been related to type 1 diabetes, an autoimmune disease characterized by pancreatic β-cell destruction mediated by autoreactive T lymphocytes. Non-obese diabetic (NOD) mice represent a suitable model to study type 1 diabetes, as they develop the disease like humans. We previously described important thymic alterations in these animals such as the development of giant perivascular spaces (PVS), characterized by the retention of T and B cells, intermingled with an ECM network, and associated with a defect in the expression of the fibronectin receptor VLA-5 and reduced sphingosine-1-phosphate receptor expression on developing thymocytes. In order to investigate galectin-3 expression in thymic microenvironmental cells and verify its interaction with cells and ECM molecules in PVS, we performed immunofluorescence following colocalization analysis in the thymic parenchyma of pre-diabetic NOD mice by confocal microscopy. In addition, thymocyte migration assays were performed to evaluate the effect of galectin-3 on NOD thymocyte migration. Herein, we showed a significant enhancement of colocalization with cortical and medullary thymic epithelial cells in NOD mice, as compared to controls. In the giant PVS of these animals, we observed a heterogeneous distribution of galectin-3, predominantly found in clusters of B lymphocytes and dendritic cells. Functionally, NOD thymocyte migratory response towards galectin-3 was impaired and a similar decrease was seen in transendothelial thymocyte migration. Taken together, our data provide the histological and functional background for a potential defective thymocyte migration involving galectin-3, thus placing this molecule as a further player in the intrathymic disturbances observed in pre-diabetic NOD mice.
Authors
- Tiago Dutra Pereira Ramos
- Daniella Arêas Mendes‐da‐Cruz (ORCID: https://orcid.org/0000-0003-3697-1506)
- Julia P. Lemos (ORCID: https://orcid.org/0000-0002-0436-6849)
- Ana Lúcia Marques Ventura (ORCID: https://orcid.org/0000-0002-4323-4451)
- Roger Chammas (ORCID: https://orcid.org/0000-0003-0342-8726)
- Carla Eponina Carvalho-Pinto (ORCID: https://orcid.org/0000-0002-1815-8418)
- Wilson Savino
- Déa Maria Serra Villa‐Verde
Institutions
- Universidade Federal Fluminense (BR)
- Universidade de São Paulo (BR)
- Instituto do Câncer do Estado de São Paulo (BR)
- Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo (BR)
- Fundação Oswaldo Cruz (BR)
Publication Details
- Journal
- Frontiers in Endocrinology
- Published
- 2024-10-17
- DOI
- https://doi.org/10.3389/fendo.2024.1200935
- Primary Topic
- Galectins and Cancer Biology
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
- Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro
- Fundação Oswaldo Cruz